nicardipine has been researched along with Cardiac Failure in 32 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been proposed that worsening of heart failure with dihydropyridines, such as nicardipine, is related to the activation of the neuroendocrine system." | 9.08 | Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy. ( Benatar, D; Gheorghiade, M; Hall, V; Reddy, S, 1998) |
| "The acute and chronic haemodynamic effects of nicardipine were studied, at rest and during exercise, in 10 post-myocardial infarction patients with latent cardiac failure and no signs of residual myocardial ischaemia." | 9.06 | Acute and chronic effects of nicardipine on rest and exercise haemodynamics in post-myocardial infarction patients with latent cardiac failure. ( La Rovere, MT; Mortara, A; Opasich, C; Specchia, G, 1989) |
| "Acute and chronic hemodynamic effects at rest and during exercise of a new dihydropyridine calcium antagonist, nicardipine hydrochloride, were studied in 10 patients with chronic heart failure." | 9.06 | Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure. ( Burlew, BS; Gheorghiade, M; Goldberg, AD; Goldstein, S; Jafri, SM, 1987) |
| "The authors report a heart failure and a collapse following concurrently administration of nicardipine and magnesium sulfate." | 7.78 | [Complications of association magnesium sulfate with nicardipine during preeclampsia: report of 2 cases]. ( Alassas, N; Carles, G; Dallah, F; Helou, J; Ibrahim, N, 2012) |
| "Cardiovascular effects of nicardipine hydrochloride (NIC, CAS 54527-84-3, Perdipine), a calcium channel blocker, were investigated in anesthetized normal dogs and dogs with acute heart failure (AHF), and compared with those of nitroglycerin (NTG)." | 7.70 | Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure. ( Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S, 1998) |
| "The effect of nicardipine hydrochloride (NIC, CAS 54527-84-3, Perdipine) on myocardial metabolism was investigated in an experimental model of ischemic acute heart failure (AHF) induced by coronary ligation in anesthetized dogs." | 7.70 | Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 2: Effect on myocardial metabolism. ( Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S, 1998) |
| "Acute effects of intravenous nicardipine (10 micrograms/kg) on systemic hemodynamics and cardiac function were evaluated in 17 patients with a healed myocardial infarction and no evidence of congestive heart failure." | 7.68 | Acute effects of intravenous nicardipine on hemodynamics and cardiac function in patients with a healed myocardial infarction and no evidence of congestive heart failure. ( Ishii, M; Ogawa, T; Sekiguchi, T; Sugishita, Y; Ushiyama, K; Yasui, K, 1991) |
| "The hemodynamic response to vasodilation induced by the new calcium channel antagonist nicardipine was studied in 10 patients with severe, chronic congestive heart failure." | 7.67 | Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure. ( Cody, RJ; Kubo, SH; Lystash, J; Ryman, KS; Stone, G, 1986) |
| "The effects of intravenous nicardipine (10 mg) on some aspects of left ventricular function have been studied with a radioisotope method in 10 male patients in chronic heart failure (NYHA Class II and III)." | 7.67 | Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study. ( Caruana, MP; Harlow, BJ; Kohli, RS; Lahiri, A; Raftery, EB; Robinson, CW; Tovey, J, 1984) |
| "Twenty patients in a stable condition suffering from congestive heart failure were treated with digoxin for at least three weeks and then with nicardipine concomitantly for five days." | 7.67 | Nicardipine does not significantly affect serum digoxin concentrations at the steady state of patients with congestive heart failure. ( Commeau, P; Debruyne, D; Grollier, G; Huret, B; Moulin, M; Scanu, P, 1989) |
| "Nicardipine, a new dihydropyridine calcium channel blocker, has been investigated for the treatment of coronary artery disease and heart failure." | 7.67 | Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. ( Aroney, CN; Boucher, CA; Dec, GW; Fifer, MA; Semigran, MJ, 1989) |
| "We evaluated the immediate hemodynamic response to nicardipine, administered as an intravenous bolus and 30-minute sustaining infusion, in 10 patients with systemic hypertension (HTN) and 10 patients with chronic congestive heart failure (CHF)." | 7.67 | Influence of baseline hemodynamic status and sympathetic activity on the response to nicardipine, a new dihydropyridine, in patients with hypertension or chronic congestive heart failure. ( Cody, RJ; Kubo, SH; Ryman, KS; Shaknovich, A, 1987) |
| " Patients responders, 8 males and 2 females, mean age 57 +/- 10 years, have been treated with oral nicardipine administered at the dosage of 40 mg td for 3 months." | 5.28 | [Delayed-action nicardipine in the prolonged treatment of chronic congestive heart failure in responsive subjects]. ( Masciocco, L; Mattioli, AV; Mattioli, G; Tondi, S, 1989) |
| "Nicardipine is a new calcium ion antagonist with vasodilating properties which has been shown to be effective in the treatment of hypertension and angina." | 5.27 | Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study. ( Caruana, MP; Kohli, RS; Lahiri, A; Raftery, EB; Robinson, CW, 1986) |
| "It has been proposed that worsening of heart failure with dihydropyridines, such as nicardipine, is related to the activation of the neuroendocrine system." | 5.08 | Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy. ( Benatar, D; Gheorghiade, M; Hall, V; Reddy, S, 1998) |
| "The acute and chronic haemodynamic effects of nicardipine were studied, at rest and during exercise, in 10 post-myocardial infarction patients with latent cardiac failure and no signs of residual myocardial ischaemia." | 5.06 | Acute and chronic effects of nicardipine on rest and exercise haemodynamics in post-myocardial infarction patients with latent cardiac failure. ( La Rovere, MT; Mortara, A; Opasich, C; Specchia, G, 1989) |
| "Acute and chronic hemodynamic effects at rest and during exercise of a new dihydropyridine calcium antagonist, nicardipine hydrochloride, were studied in 10 patients with chronic heart failure." | 5.06 | Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure. ( Burlew, BS; Gheorghiade, M; Goldberg, AD; Goldstein, S; Jafri, SM, 1987) |
| " Although the role of antihypertensive therapy in regression of LVH remains controversial, the calcium antagonist nicardipine appears to have an important role to play in the treatment of LVH in hypertension and in congestive heart failure." | 4.78 | Therapeutic advances in the treatment of left ventricular hypertrophy. ( Natsume, T, 1993) |
| "The authors report a heart failure and a collapse following concurrently administration of nicardipine and magnesium sulfate." | 3.78 | [Complications of association magnesium sulfate with nicardipine during preeclampsia: report of 2 cases]. ( Alassas, N; Carles, G; Dallah, F; Helou, J; Ibrahim, N, 2012) |
| "Cardiovascular effects of nicardipine hydrochloride (NIC, CAS 54527-84-3, Perdipine), a calcium channel blocker, were investigated in anesthetized normal dogs and dogs with acute heart failure (AHF), and compared with those of nitroglycerin (NTG)." | 3.70 | Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure. ( Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S, 1998) |
| "The effect of nicardipine hydrochloride (NIC, CAS 54527-84-3, Perdipine) on myocardial metabolism was investigated in an experimental model of ischemic acute heart failure (AHF) induced by coronary ligation in anesthetized dogs." | 3.70 | Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 2: Effect on myocardial metabolism. ( Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S, 1998) |
| "Acute effects of intravenous nicardipine (10 micrograms/kg) on systemic hemodynamics and cardiac function were evaluated in 17 patients with a healed myocardial infarction and no evidence of congestive heart failure." | 3.68 | Acute effects of intravenous nicardipine on hemodynamics and cardiac function in patients with a healed myocardial infarction and no evidence of congestive heart failure. ( Ishii, M; Ogawa, T; Sekiguchi, T; Sugishita, Y; Ushiyama, K; Yasui, K, 1991) |
| "To assess the effect of nicardipine on left ventricular (LV) diastolic function independent of concurrent effects on loading conditions in patients with LV systolic dysfunction due to coronary artery disease, equihypotensive doses of intravenous nitroprusside and nicardipine were administered to 12 patients with congestive heart failure due to previous myocardial infarction (LV ejection fraction less than 0." | 3.68 | Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease and effect of nicardipine. ( Aroney, CN; Boucher, CA; Dec, GW; Fifer, MA; Semigran, MJ, 1991) |
| "The effects of intravenous nicardipine (10 mg) on some aspects of left ventricular function have been studied with a radioisotope method in 10 male patients in chronic heart failure (NYHA Class II and III)." | 3.67 | Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study. ( Caruana, MP; Harlow, BJ; Kohli, RS; Lahiri, A; Raftery, EB; Robinson, CW; Tovey, J, 1984) |
| " Haemodynamic responses to exercise, posture and nitrates were measured before and after 8 weeks of therapy with an arteriolar smooth muscle specific calcium antagonist, nicardipine, in eight patients with congestive heart failure (New York Heart Association class II or III)." | 3.67 | Changes in the haemodynamic responses to exercise, posture and nitrates after treatment of congestive heart failure with an arteriolar vasodilator. ( Culling, W; Dixon, MS; Sheridan, DJ; Thomas, P, 1989) |
| "Twenty patients in a stable condition suffering from congestive heart failure were treated with digoxin for at least three weeks and then with nicardipine concomitantly for five days." | 3.67 | Nicardipine does not significantly affect serum digoxin concentrations at the steady state of patients with congestive heart failure. ( Commeau, P; Debruyne, D; Grollier, G; Huret, B; Moulin, M; Scanu, P, 1989) |
| "Nicardipine, a new dihydropyridine calcium channel blocker, has been investigated for the treatment of coronary artery disease and heart failure." | 3.67 | Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. ( Aroney, CN; Boucher, CA; Dec, GW; Fifer, MA; Semigran, MJ, 1989) |
| "We evaluated the immediate hemodynamic response to nicardipine, administered as an intravenous bolus and 30-minute sustaining infusion, in 10 patients with systemic hypertension (HTN) and 10 patients with chronic congestive heart failure (CHF)." | 3.67 | Influence of baseline hemodynamic status and sympathetic activity on the response to nicardipine, a new dihydropyridine, in patients with hypertension or chronic congestive heart failure. ( Cody, RJ; Kubo, SH; Ryman, KS; Shaknovich, A, 1987) |
| "The hemodynamic response to vasodilation induced by the new calcium channel antagonist nicardipine was studied in 10 patients with severe, chronic congestive heart failure." | 3.67 | Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure. ( Cody, RJ; Kubo, SH; Lystash, J; Ryman, KS; Stone, G, 1986) |
| "Cardiovascular diseases are a leading cause of hospitalizations and death in the United States and elsewhere in the world." | 2.46 | Cardiovascular pharmacology: an update. ( Fox, CJ; Kaye, AD; Liu, H; Zhang, S, 2010) |
| " Nicardipine appeared to be safe and effective in controlling hypertension in these patients." | 1.31 | Nicardipine is a safe and effective agent in pediatric hypertensive emergencies. ( Sakarcan, A; Tenney, F, 2000) |
| " Patients responders, 8 males and 2 females, mean age 57 +/- 10 years, have been treated with oral nicardipine administered at the dosage of 40 mg td for 3 months." | 1.28 | [Delayed-action nicardipine in the prolonged treatment of chronic congestive heart failure in responsive subjects]. ( Masciocco, L; Mattioli, AV; Mattioli, G; Tondi, S, 1989) |
| "Nicardipine is a new slow channel calcium blocker." | 1.27 | The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure. ( Evans, TR; Greenbaum, RA; Wan, S, 1986) |
| "Nicardipine is a new calcium ion antagonist with vasodilating properties which has been shown to be effective in the treatment of hypertension and angina." | 1.27 | Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study. ( Caruana, MP; Kohli, RS; Lahiri, A; Raftery, EB; Robinson, CW, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (53.13) | 18.7374 |
| 1990's | 11 (34.38) | 18.2507 |
| 2000's | 1 (3.13) | 29.6817 |
| 2010's | 2 (6.25) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Ibarra, F | 1 |
| Holzmann, S | 1 |
| Shah, S | 1 |
| Fountain, C | 1 |
| Saleh, S | 1 |
| Kapoor, V | 1 |
| Dang, T | 1 |
| Liu, H | 1 |
| Fox, CJ | 1 |
| Zhang, S | 1 |
| Kaye, AD | 1 |
| Carles, G | 1 |
| Helou, J | 1 |
| Alassas, N | 1 |
| Dallah, F | 1 |
| Ibrahim, N | 1 |
| Lahiri, A | 2 |
| Robinson, CW | 2 |
| Tovey, J | 1 |
| Caruana, MP | 2 |
| Kohli, RS | 2 |
| Harlow, BJ | 1 |
| Raftery, EB | 2 |
| Sy, J | 1 |
| Vitarelli, A | 1 |
| Gheorghiade, M | 3 |
| Natsume, T | 1 |
| White, CM | 1 |
| Saitoh, C | 2 |
| Momose, K | 2 |
| Tanaka, H | 2 |
| Sato, S | 2 |
| Taguchi, K | 2 |
| Saitoh, M | 2 |
| Maehara, J | 2 |
| Asano, M | 2 |
| Usuda, S | 2 |
| Rüchardt, A | 1 |
| Eisenlohr, H | 1 |
| Lydtin, H | 1 |
| Benatar, D | 1 |
| Hall, V | 1 |
| Reddy, S | 1 |
| Tenney, F | 1 |
| Sakarcan, A | 1 |
| Tamburino, C | 1 |
| Russo, G | 1 |
| Di Paola, R | 1 |
| Passaniti, A | 1 |
| Zisa, MB | 1 |
| Felis, S | 1 |
| Calvi, V | 1 |
| Alì, A | 1 |
| Cinnirella, C | 1 |
| Giuffrida, G | 1 |
| Ogawa, T | 1 |
| Sekiguchi, T | 1 |
| Ishii, M | 1 |
| Ushiyama, K | 1 |
| Yasui, K | 1 |
| Sugishita, Y | 1 |
| Aroney, CN | 2 |
| Semigran, MJ | 2 |
| Dec, GW | 2 |
| Boucher, CA | 2 |
| Fifer, MA | 2 |
| Pepine, CJ | 1 |
| Lambert, CR | 1 |
| Thomas, P | 1 |
| Dixon, MS | 1 |
| Culling, W | 1 |
| Sheridan, DJ | 1 |
| Cody, RJ | 4 |
| Riew, KD | 1 |
| Kubo, SH | 3 |
| Tondi, S | 2 |
| Zennaro, RG | 1 |
| Masciocco, L | 2 |
| Mattioli, G | 2 |
| Mattioli, AV | 1 |
| La Rovere, MT | 1 |
| Mortara, A | 1 |
| Opasich, C | 1 |
| Specchia, G | 1 |
| Debruyne, D | 1 |
| Commeau, P | 1 |
| Grollier, G | 1 |
| Huret, B | 1 |
| Scanu, P | 1 |
| Moulin, M | 1 |
| Mizutani, H | 1 |
| Ishizaka, K | 1 |
| Konagaya, T | 1 |
| Kishimoto, H | 1 |
| Sudo, K | 1 |
| Maekawa, M | 1 |
| Kanno, T | 1 |
| Yasumi, T | 1 |
| Barbieri, L | 1 |
| Mestroni, L | 1 |
| Camerini, F | 1 |
| Burlew, BS | 1 |
| Jafri, SM | 1 |
| Goldberg, AD | 1 |
| Goldstein, S | 1 |
| Ryman, KS | 2 |
| Shaknovich, A | 1 |
| Mazzola, C | 1 |
| Vaccarella, A | 1 |
| Guffanti, E | 1 |
| Colnago, R | 1 |
| Scarpazza, P | 1 |
| Turri, DR | 1 |
| Fiorella, G | 1 |
| Greenbaum, RA | 1 |
| Wan, S | 1 |
| Evans, TR | 1 |
| Lystash, J | 1 |
| Stone, G | 1 |
6 reviews available for nicardipine and Cardiac Failure
| Article | Year |
|---|---|
Cardiovascular pharmacology: an update.
Topics: Animals; Cardiovascular Agents; Cardiovascular Diseases; Diastole; Heart Failure; Humans; Hydrazones | 2010 |
Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
Topics: Acute Disease; Calcium Channel Blockers; Chronic Disease; Dobutamine; Dopamine; Dose-Response Relati | 1993 |
Therapeutic advances in the treatment of left ventricular hypertrophy.
Topics: Animals; Antihypertensive Agents; Heart Failure; Hemodynamics; Humans; Hypertension; Hypertrophy, Le | 1993 |
Calcium channel blockers in left ventricular dysfunction or congestive heart failure.
Topics: Amlodipine; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Felodipine; Heart Failure | 1997 |
Cardiovascular effects of nicardipine.
Topics: Animals; Arrhythmias, Cardiac; Cardiovascular System; Coronary Disease; Heart; Heart Failure; Hemody | 1990 |
[Calcium antagonists in congestive heart failure].
Topics: Calcium Channel Blockers; Cardiomyopathy, Dilated; Diltiazem; Felodipine; Heart Failure; Hemodynamic | 1988 |
3 trials available for nicardipine and Cardiac Failure
| Article | Year |
|---|---|
Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Captopril; Ca | 1998 |
Acute and chronic effects of nicardipine on rest and exercise haemodynamics in post-myocardial infarction patients with latent cardiac failure.
Topics: Clinical Trials as Topic; Exercise Test; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myo | 1989 |
Acute and chronic hemodynamic effects of nicardipine hydrochloride in patients with heart failure.
Topics: Administration, Oral; Clinical Trials as Topic; Exercise Test; Female; Follow-Up Studies; Heart Fail | 1987 |
23 other studies available for nicardipine and Cardiac Failure
| Article | Year |
|---|---|
Utility of nicardipine in the management of hypertensive crises in adults with reduced ejection fractions.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Bradycardia; Heart Failure; Humans; Hypertension; Hy | 2024 |
[Complications of association magnesium sulfate with nicardipine during preeclampsia: report of 2 cases].
Topics: Adolescent; Adult; Calcium Channel Blockers; Cesarean Section; Depression, Chemical; Drug Interactio | 2012 |
Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study.
Topics: Adult; Aged; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Heart Failure; Heart Rate; He | 1984 |
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Topics: Acute Disease; Adrenergic beta-Agonists; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calciu | 1998 |
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 2: Effect on myocardial metabolism.
Topics: Acute Disease; Anesthesia; Animals; Calcium Channel Blockers; Dogs; Female; Heart Failure; Hemodynam | 1998 |
[Myocardial involvement in carrier states for Duchenne muscular dystrophy. A rare cause of supraventricular arrhythmia].
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Fi | 1998 |
Nicardipine is a safe and effective agent in pediatric hypertensive emergencies.
Topics: Adolescent; Calcium Channel Blockers; Child; Female; Heart Failure; Humans; Hypertension, Malignant; | 2000 |
[Bolus nicardipine in the hemodynamic assessment for heart transplantation of patients with severe failure of ischemic origin and high pulmonary resistance].
Topics: Adult; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Female; Heart Failure; Heart | 1991 |
Acute effects of intravenous nicardipine on hemodynamics and cardiac function in patients with a healed myocardial infarction and no evidence of congestive heart failure.
Topics: Adult; Aged; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Middle Aged; Myocardial In | 1991 |
Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease and effect of nicardipine.
Topics: Atrial Function, Right; Blood Pressure; Cardiac Output; Coronary Disease; Diastole; Female; Gated Bl | 1991 |
Changes in the haemodynamic responses to exercise, posture and nitrates after treatment of congestive heart failure with an arteriolar vasodilator.
Topics: Adult; Aged; Cardiac Output; Exercise; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nicar | 1989 |
Reversal of a calcium-mediated vasoconstrictor component in patients with congestive heart failure.
Topics: Calcium Channels; Dose-Response Relationship, Drug; Female; Forearm; Heart Failure; Hemodynamics; Hu | 1989 |
[Acute hemodynamic effects of nicardipine in patients with chronic congestive heart failure].
Topics: Aged; Drug Evaluation; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nicardipine | 1989 |
[Delayed-action nicardipine in the prolonged treatment of chronic congestive heart failure in responsive subjects].
Topics: Administration, Oral; Aged; Delayed-Action Preparations; Drug Evaluation; Exercise Test; Female; Hea | 1989 |
Nicardipine does not significantly affect serum digoxin concentrations at the steady state of patients with congestive heart failure.
Topics: Aged; Digoxin; Drug Synergism; Female; Heart Failure; Humans; Male; Middle Aged; Nicardipine | 1989 |
[The ebb and flow of LDH-IgG complexes influenced by the administered drugs].
Topics: Autoantibodies; Chronic Disease; Heart Failure; Hepatitis; Humans; Immunoglobulin G; L-Lactate Dehyd | 1989 |
Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis.
Topics: Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Nicardipine; | 1989 |
Influence of baseline hemodynamic status and sympathetic activity on the response to nicardipine, a new dihydropyridine, in patients with hypertension or chronic congestive heart failure.
Topics: Adult; Aged; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nicardipi | 1987 |
Use of invasive ergometric exercise to assess the hemodynamic response to nicardipine.
Topics: Adult; Aged; Chronic Disease; Depression, Chemical; Drug Evaluation; Exercise Test; Female; Heart Fa | 1987 |
Effects of nicardipine and nifedipine in chronic heart failure: a non invasive study.
Topics: Aged; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1987 |
Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study.
Topics: Administration, Oral; Adult; Aged; Calcium Channel Blockers; Cardiac Output; Dose-Response Relations | 1986 |
The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.
Topics: Adult; Aged; Calcium Channel Blockers; Dose-Response Relationship, Drug; Female; Heart Failure; Hemo | 1986 |
Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle A | 1986 |